Intervacc AB: directors' dealings · Finland · FIN-FSA FI:intervacc-ab SE0009607252 FI FI · FIN-FSA Mcap 408M€ Healthcare
Explore the full insider trade history of Intervacc AB, a listed issuer based in Finland. Shares are quoted on FI FI, under the oversight of FIN-FSA. Operating in the Healthcare sector, Intervacc AB has published 6 insider filings. Market capitalisation: €408.3m. The latest transaction was reported on 19 May 2026 (Purchase). Among the most active insiders: Carl Johan Dalsgaard. The full history is free.
Financial data FY ended December 2025 · cache
Analyst consensus
1 analysts 2.10 € Target 2.10 €(+75%) 2.10 €
Income statement
Revenue 20.1 M€
Gross profit −11.5 M€ -57% margin
Net income −80.8 M€ -402.3% margin
Valuation
PER (forward) -5.0x
P/Book 1.7x
Balance sheet & cash
Market cap 408.3 M€
Total debt 108 k€
Free Cash Flow −66.9 M€
Debt / Equity 0%
Profitability & ownership
ROE -30.0%
ROA -18.0%
% insiders 19.3%
% institutions 34.4%
Last declaration on 19 May 2026
Declarations 6 total
Executives ● Purchase30 FIN-FSA
€2m 150,000 shares @ €12.5436 0.46% mcap 99.2% of flow SE0009607252⌘
Aktie
FI:A003Y813-1 · 19 May 2026
Ideal exit: 13 Feb 2027 (T+270) Executives ● Purchase31 FIN-FSA
€11,598 200,000 shares @ €0.058 0.0028% mcap 35.4% of flow
Aktie
FI:A003W618-1 · 27 Feb 2026
Ideal exit: 24 Nov 2026 (T+270) Executives ● Purchase24 FIN-FSA
€8,923 130,000 shares @ €0.0686 0.0022% mcap 100.0% of flow SE0009607252⌘
Aktie
FI:A003W620-1 · 18 Feb 2026
Ideal exit: 15 Nov 2026 (T+270) Executives ● Purchase29 FIN-FSA
€7,019 100,000 shares @ €0.0702 0.0017% mcap 21.5% of flow SE0009607252⌘
Aktie
FI:A003W345-1 · 20 Feb 2026
Ideal exit: 17 Nov 2026 (T+270) Executives ● Purchase31 FIN-FSA
€14,103 200,000 shares @ €0.0705 0.0035% mcap 43.1% of flow SE0009607252⌘
Aktie
FI:A003W152-1 · 18 Feb 2026
Ideal exit: 15 Nov 2026 (T+270) Executives ● Purchase20 FIN-FSA
€15,917 180,000 shares @ €0.0884 0.0039% mcap 100.0% of flow SE0009607252⌘
Aktie
FI:A003Q915-1 · 21 Jul 2025
Ideal exit: 17 Apr 2026 (T+270)